FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

91314000: Furazolidone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
151302019 Furazolidone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
834603015 Furazolidone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
813681000172117 furazolidone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Furazolidone Is a Antiprotozoal drug false Inferred relationship Some
Furazolidone Is a médicament antibactérien false Inferred relationship Some
Furazolidone Is a Antiprotozoal false Inferred relationship Some
Furazolidone Is a Nitrofuran derivative true Inferred relationship Some
Furazolidone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Furazolidone Is a Antibacterial true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing furazolidone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 1
Furazolidone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 1
Product containing only furazolidone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 1
Furazolidone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 1
Product containing precisely furazolidone 6 milligram/1 milliliter and metronidazole (as metronidazole benzoate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Furazolidone Inferred relationship Some 2
Product containing precisely furazolidone 6 milligram/1 milliliter and metronidazole (as metronidazole benzoate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Furazolidone Inferred relationship Some 2
Product containing furazolidone and metronidazole (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 2
Furazolidone and metronidazole only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 2
Product containing only furazolidone and metronidazole in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 2
Furazolidone- and metronidazole-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Furazolidone Inferred relationship Some 2
Furazolidone 100 mg and metronidazole 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Furazolidone Inferred relationship Some 2
Furazolidone 100 mg and metronidazole 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Furazolidone Inferred relationship Some 2

This concept is not in any reference sets

Back to Start